1. Home
  2. ENTA vs ASG Comparison

ENTA vs ASG Comparison

Compare ENTA & ASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$15.22

Market Cap

374.6M

Sector

Health Care

ML Signal

HOLD

ASG

Liberty All-Star Growth Fund Inc.

HOLD

Current Price

$5.28

Market Cap

328.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTA
ASG
Founded
1995
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
374.6M
328.8M
IPO Year
2012
1995

Fundamental Metrics

Financial Performance
Metric
ENTA
ASG
Price
$15.22
$5.28
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$20.40
N/A
AVG Volume (30 Days)
123.3K
310.8K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
29.93
N/A
EPS
N/A
N/A
Revenue
$102,814,000.00
N/A
Revenue This Year
$7.76
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.48
N/A
52 Week Low
$5.55
$4.55
52 Week High
$17.15
$5.69

Technical Indicators

Market Signals
Indicator
ENTA
ASG
Relative Strength Index (RSI) 67.77 58.24
Support Level $12.91 $5.23
Resistance Level $15.37 $5.57
Average True Range (ATR) 0.76 0.07
MACD 0.16 0.01
Stochastic Oscillator 81.47 71.93

Price Performance

Historical Comparison
ENTA
ASG

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About ASG Liberty All-Star Growth Fund Inc.

Liberty All Star Growth Fund Inc is the United States based diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment in a diversified portfolio of equity securities. The company's portfolio of investments consists of different industries such as consumer discretionary, consumer staples, healthcare, industrial, information technology and others.

Share on Social Networks: